[1]
Borkar, N., Gote, S., Salvi, P. and Khobragade, K. 2025. Physicians’ perspectives on irritable bowel syndrome, diagnosis and management in India: insights from in-clinic questionnaire-based survey study with a focus on Rifaximin. International Journal Of Community Medicine And Public Health. 12, 11 (Oct. 2025), 5138–5142. DOI:https://doi.org/10.18203/2394-6040.ijcmph20253696.